Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-17 to 2022-12-16
Current total value of award: $849016
Description: RANK LIGAND INHIBITION - A POTENTIAL CHEMOPREVENTION STRATEGY FOR WOMEN AT HIGH GENETIC RISK OF BREAST CANCER